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https://doi.org/10.1016/j.stemcr.2018.01.022SUMMARYInvestigation of human muscle regeneration requires robust methods to purify and transplant muscle stem and progenitor cells that
collectively constitute the human satellite cell (HuSC) pool. Existing approaches have yet to make HuSCs widely accessible for re-
searchers, and as a result human muscle stem cell research has advanced slowly. Here, we describe a robust and predictable HuSC
purification process that is effective for each human skeletal muscle tested and the development of storage protocols and transplantation
models in dystrophin-deficient and wild-type recipients. Enzymatic digestion, magnetic column depletion, and 6-marker flow-cytomet-
ric purification enable separation of 104 highly enrichedHuSCs per gram ofmuscle. Cryostorage of HuSCs preserves viability, phenotype,
and transplantation potential. Development of enhanced and species-specific transplantation protocols enabled serial HuSC xenotrans-
plantation and recovery. These protocols and models provide an accessible system for basic and translational investigation and clinical
development of HuSCs.INTRODUCTION
Muscle regeneration inmost species ismediated by satellite
cells, anatomically defined based on their position between
the skeletal muscle fiber plasma membrane and the basal
lamina (Mauro, 1961). Satellite cells are a heterogeneous
pool of muscle progenitors, a subset of which fulfill criteria
of adult stem cells in that they engraft, proliferate, respond
to injury by regenerating mature muscle, reoccupy the
muscle satellite cell niche, and self-renew (Collins et al.,
2005; Kuang et al., 2007; Montarras et al., 2005; Sacco
et al., 2008; Sherwood et al., 2004). Endogenous character-
istics of satellite cell populations, including activation state
and stemness, are rapidly altered in culture (Brimah et al.,
2004; Charville et al., 2015; Cooper et al., 2001; Montarras
et al., 2005), limiting investigation of in vivo properties,
natural heterogeneity, and regenerative capacity. For hu-
man satellite cells (HuSCs), experimental tractability is
further complicated by source scarcity and less predictable
yield that may in turn be related to variable source proper-
ties such as muscle type, age, and delay in preparation after
tissue procurement. This limits preclinical investigation
and slows clinical translation.
Several standard and classical experimental paradigms
used to study tissue stem cells, such as serial transplanta-
tion, have been unavailable for use in human muscle
stem cell biology because of difficulty obtaining adequate
tissue, limited ability to isolate pure populations of satellite1160 Stem Cell Reports j Vol. 10 j 1160–1174 j March 13, 2018 j ª 2018 The
This is an open access article under the CC BY-NC-ND license (http://creativcells, and challenges with xenotransplantation. Whereas
the mouse has proved extremely valuable for understand-
ing muscle satellite cell biology that is highly relevant to
humans, there are limitations in terms of how closely hu-
man muscle biology will mimic that of laboratory rodents.
Therefore it is imperative to study naturally occurring
HuSCs in order to address clinical muscle disorders.
Although endogenous human muscle progenitors and sat-
ellite cells have recently been characterized and trans-
planted (Alexander et al., 2016; Castiglioni et al., 2014;
Charville et al., 2015; Uezumi et al., 2016; Xu et al.,
2015), the lack of readily available sources of preserved
HuSCs has sequesteredHuSC investigation frommostmus-
cle researchers. Overcoming current limitations in human
muscle stem cell researchwill advancemuscle regeneration
research and should lead to more precise clarification of
muscle stem cell targets relevant for durable and impactful
therapeutic interventions.
Here, we report and provide methods for high-grade pu-
rification of satellite cells from adult human skeletalmuscle
and methods for predictable isolation, yield, and storage,
that together enable more sophisticated and better
controlled experimentation than was previously feasible.
Cryopreservation retains satellite cell properties and per-
mits direct comparisons of same-source satellite cells after
different treatments. Improved engraftment techniques
and methods to separate HuSCs from mouse tissue have
enabled serial transplantation of human satellite stem cells.Author(s).
ecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Optimized Isolation of Human Satellite Cells from Postnatal Muscle Tissue
(A) Representative flow-cytometry profiles of HuSCs gated for live singlets expressing the surface marker profile CD31/CD34/CD45/
CXCR4+/CD29+/CD56+. Cells gated are outlined in black within each plot. The percentage of events in each gating step is shown in each plot
(n = 57).
(B) HuSCs were collected stained for PAX7 expression (n = 3). Scale bar 100 mm.
(C) Bar graph representation of PAX7 immunoreactivity in seeded HuSCs (n = 3).
(D) Representative histogram of HuSC diameters after a satellite cell isolation from a single muscle sample (n = 3). Left peak consists of
small debris.
(E) Bar plot showing the average number of HuSCs isolated per gram, stratified by muscle type. There were no statistically significant
differences (n = at least two samples per muscle type).
(legend continued on next page)
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The approaches developed in this study resolve technical
hindrances impeding HuSC and human muscle stem cell
investigation.RESULTS
Efficient High-Yield Purification of Satellite Cells from
Human Skeletal Muscles
Building on our previously published strategy for isolation
of HuSCs (Garcia et al., 2017; Xu et al., 2015) we developed
an enhanced protocol that standardizes yield and greatly
improves isolation efficiency (see Experimental Procedures
and Supplemental Experimental Procedures for details of
the protocol). In agreement with prior reports by others
(Bareja et al., 2014; Castiglioni et al., 2014) we found that
CXCR4 marks HuSCs. Isolation strategies that solely use
either CXCR4 or CD29/CD56-positive markers require
more conservative gating of incompletely separated popu-
lations to avoid capturing potential non-satellite cells,
therefore also potentially excluding satellite cells that are
not well separated (Figure S1). For example, the rightmost
panels (top three rows) and second from right panels (bot-
tom three rows) of Figure S1A show different experiments
that have variable overlap of the populations. We also
determined that satellite cells in adult human muscle are
negative for CD34 surface expression (Figure S2), in
contrast to mouse satellite cells (Beauchamp et al., 2000;
Fukada et al., 2004; Montarras et al., 2005; Sherwood
et al., 2004) and in agreementwith prior reports identifying
CD34-negative unipotent human myogenic cells (Pisani
et al., 2010) and CD34-low or -negative fetal and adult
HuSCs (Castiglioni et al., 2014). Negative selection with
CD34 was therefore introduced into the purification strat-
egy. To enhance separation, we developed a combinatorial
strategy using negative and stepwise positive selection. We
also investigated various tissue dissociation procedures and
found that enzymatic sample digestion with the use of
collagenase and trypsin was superior to pronase and colla-
genase that we had used previously. Optimized tissue disso-
ciation preserved epitopes of the surface proteins assessed
in this study, as demonstrated by similar fluorescence in-
tensity with or without trypsin, and resulted in improved
separation of satellite cells from non-satellite cells (Fig-(F) Bar plot depicting the average number of cells isolated per gram stra
of the age groups when grouped by age (p = 0.610) or with linear reg
(G) Bar plot depicting the average number of cells isolated per gram sep
(p = 0.343).
(H) Bar plot depicting the average number of cells isolated per gram arr
among any of the weight groups.
Data presented as mean ± SEM. See Table S1 for complete sample de
experiments, and Table S2 for all statistics and p values. See also Fig
1162 Stem Cell Reports j Vol. 10 j 1160–1174 j March 13, 2018ure S2). Possibly, other satellite cell surface proteins that
were not evaluated here could be affected by the enzymatic
digestion protocol. Using these advances, an optimized
isolation protocol was developed: Muscle digestion is fol-
lowed with depletion of endothelial and hematopoietic
cells using magnetic column separation with CD31 and
CD45 metal beads. Remaining cells are then sorted via
flow cytometry for viable singlets with the following
markers: Sytox/CD31/CD34/CD45/CXCR4+/CD29+/
CD56+ (Figure 1A). Primary gatingwith simultaneous nega-
tive depletion and positive selection with CXCR4 initially
plots satellite cells as distinct from the majority of non-
satellite cells, and subsequent gating on CD56/CD29
further distinguished highly separable and pure HuSCs.
CXCR4 also separates the satellite cell population from
small autofluorescent fiber fragments, significantly
reducing the sorting abort rate. We have found that this
strategy greatly improves efficiency during sorting. In
particular, the satellite cell population can be rapidly iden-
tified during the initial part of the flow run, and the abso-
lute time required to sort a given sample is reduced, partly
because addition of trypsin reduces the difficult to digest
muscle fiber pellet. Examples of various satellite cell isola-
tions are shown in Figure S1, highlighting the above
improvements, which together contribute to high and
reproducible HuSC yields. Reliability of successful isolation
is ensured by the use of the sequential positive selection,
which enables separation of HuSCs in the occasional
instance of technically substandard separation in one
step, as shown in row 4 of Figure S1. Isolated cells were
confirmed to be highly purified by detectable PAX7 immu-
nostaining in nearly all cells (95% ± 0.58%) (Figures 1B and
1C). Average satellite cell size, determined by Moxi Flow as
per the manufacturer’s instructions, was 8.2 mm in diam-
eter with a range of 6–12.5 mm (Figure 1D). In ten different
skeletal muscle types from adults >18 years of age,
including two cranial skeletal muscles (tongue and tempo-
ralis), we isolated roughly similar numbers of cells from
each muscle on the day after biopsy. The most frequent
samples yielded 10,000 or more HuSCs per gram of tissue
(Figure 1E). Yield was slightly decreased in samples from
elderly (>81 years) individuals (Figure 1F). The yield of sat-
ellite cells isolated from tissues of females tended to in-
crease when controlled for age andmuscle type, but limitedtified by donor age. There were no statistical differences among any
ression analysis (p = 0.474).
arated by donor gender shows no statistically significant difference
anged by tissue weight shows no statistically significant differences
tails and individual n values, which denote individual donors and
ures S1 and S2.
sample size likely precluded definitive determination of
variations based on sex (Figure 1G). Satellite cell isolation
was efficient over a wide range of starting tissue weights
from less than 1 g to 6 g. There was increased variability
of yield from larger tissue samples, likely related to
technical aspects of upscaling the processing (Figure 1H).
Together, these technical advances provide a refined pro-
tocol for reproducible, stringent, and efficient HuSC
isolation.
Increased Engraftment of Xenotransplanted Human
Satellite Cells by Broad Transplant Distribution
To evaluate whether the extent of HuSC engraftment into
minimally damaged muscle could be enhanced, we trans-
planted 10-fold variable numbers of HuSCs. Nod SCID
Gamma (NSG) mice underwent hindlimb irradiation (see
Experimental Procedures) and were transplanted with
either 1,000, 5,000, or 10,000 HuSCs using a single injec-
tion into the tibialis anterior (TA) muscle (Figure 2A).
Engraftment was evaluated using immunostaining for
human DYSTROPHIN and PAX7 with human SPECTRIN/
LAMIN A/C. While engraftment was efficient over the
range of transplantation cell dose, the number of engrafted
human fibers did not differ among mice transplanted with
1,000, 5,000, or 10,000 satellite cells (Figure 2B). This
finding suggested that locally transplanted cells may satu-
rate receptive niches or that engraftment may be otherwise
limited in the acute period of this model, and since neither
murine satellite cells (Sacco et al., 2008), humanmyoblasts
(Skuk et al., 2010), or HuSCs (Xu et al., 2015)migrate signif-
icantly far from the immediate site of transplantation, we
adopted a transplantation strategy utilizing multiple injec-
tion sites. We used nine injections of approximately 5.5 mL,
each containing approximately 220 HuSCs suspended in
0.5% bupivacaine, totaling 50 mL per NSG TA. We found
that when compared with mice transplanted with a single
injection, the same dose ofHuSCdistributed inmultiple in-
jections resulted in increased engraftment area of human
fibers (Figure 2C). We observed that the proportion of en-
grafted PAX7-positive HuSCs increases as well when the
multiple-injection protocol is utilized, as evidenced by
staining for human-specific SPECTRIN combined with
the costaining of PAX7 and LAMIN A/C (Figures 2C and
S3). The average human fiber formation in mice trans-
planted with 2,000 HuSCs utilizing multiple injections
was increased to an average of 155 fibers, over a 2.5-fold in-
crease in comparisonwithmice transplantedwith the same
number of cells under the single injection protocol with an
average of 40 fibers (Figure 2D). The average number of
human-derived PAX7 cells appeared to increase in multi-
ple-injection recipient muscle, but limited sample size pre-
cluded definitive quantification (Figure 2E). This level of
engraftment corresponds to a conservatively estimatedengraftment efficiency of 1 human-derived fiber per 20
HuSCs transplanted. The engraftment data reported here
represent a conservative analysis, and it is possible that
actual engraftment was higher if some human-derived fi-
bers within the muscle did not reach the analyzed section.
This is possible since injections were done throughout the
recipient muscle. However, we have previously shown that
individual human-derived fibers generally extend along
most of the length of the recipient muscle (Xu et al.,
2015), mitigating this issue and supporting the analysis
method used here. These findings indicate a high capacity
for engraftment by individual HuSCs, and show that distri-
bution over a wider area, possibly accessing a higher num-
ber of receptive niches in the acute setting, is more impor-
tant than the absolute number of cells transplanted.
Human Satellite Cell Viability and Engraftment
Capacity Are Maintained in Stored Muscle before
Processing
The need to process muscle samples immediately after
acquisition remains an open question, and the possibility
of longer-term storage would facilitate experimentation
and sharing of valuable samples among researchers. We
therefore determined whether functioning HuSCs can be
extracted from tissue several days after biopsy. Prior work
indicated the capacity of skeletal muscle cells from human
adult muscle to survive for several days post mortem (Latil
et al., 2012). To determine whether HuSCs can be isolated
from stored muscle tissue, we isolated satellite cells from
three different post-biopsy time points: immediately
(day 0), 1 day post biopsy (day 1), and 4 days post biopsy
(day 4). Three separate muscle samples from different do-
nors were harvested and divided into 2-g pieces at the
time of biopsy. All muscle samples were stored in 30% fetal
bovine serum (FBS) at 4C until use. Each 2-g sample was
processed as described in Figure 1A at each post-biopsy
time point. Flow-cytometry profiles were similar across
the three time points and HuSCs were isolated from each
time point in similar proportions (Figure 3A). Satellite cell
yield tended to decrease from day 0 to day 4, but reproduc-
ible yieldwasmaintained at 4 days (Figure 3B). To assess cell
viability, we performed a test of cell-seeding aptitude. For
each experimental time point, cells were sorted into Tera-
saki plate wells at a density of 25 cells per well (Figure 3C),
with 20 total wells per replicate. The cells were cultured for
24 hr, at which time the wells were fixed and cell number
was quantified. Seeding of cells isolated was greater than
70% in each time point and experimental replicate. There
was no significant difference among seeded cells isolated
on day 0, day 1, or day 4. To confirm satellite cell identity,
we cultured sorted cells from each time point for 3 hr and
stained them for PAX7 (Figure S4). PAX7 expression was
not significantly different in cells isolated from theStem Cell Reports j Vol. 10 j 1160–1174 j March 13, 2018 1163
Figure 2. Enhanced Engraftment of HuSCs by Multiple-Site Injection
(A) Representative images of a conventional transplant with a single injection with 10,000 cells per TA (n = 5, biological replicates).
TA cross-sections were stained with human DYSTROPHIN (left) for human fibers or with human-specific SPECTRIN, LAMIN A/C, Laminin, and
PAX7 for HuSCs (right). Satellite cells are marked with an arrow.
(B) Bar graph representation of human fiber engraftment with varying dosage of transplanted cells. Isolated satellite cells were trans-
planted in a single injection of either 1,000 (n = 3), 5,000 (n = 9), or 10,000 (n = 5) cells. n Values denote biological replicates. Human
DYSTROPHIN-positive fibers were counted in TA cross-sections, and the y axis value indicates the number of fibers within the cross-section
containing the maximum number of human-derived fibers. The number of engrafted fibers was not significantly different among the three
groups.
(C) Satellite cells were transplanted in either a single injection (top panels) or with multiple injection sites (bottom panels) with a dose of
2,000 cells per TA. TA cross-sections were stained with human DYSTROPHIN (left) for human fibers or with human-specific SPECTRIN,
LAMIN A/C, Laminin, and PAX7 for HuSCs (right) (n = 4 biological replicates). Satellite cells are marked with arrows. Scale bars, 100 mm
(left panels; also applies to A) and 10 mm (right panels; also applies to A).
(D) Bar graph showing the engraftment of human myofibers after transplantation as assessed by human DYSTROPHIN staining (n = 4 per
group, individual mice).
(E) Bar graph showing the average engraftment of PAX7-positive HuSCs per cross-section after transplantation (n = 4 per group, individual
mice).
Data presented as mean ± SEM. *p < 0.05. All samples were processed the morning after tissue collection, within 12 hr after muscle biopsy.
All mice were analyzed 5 weeks after transplantation. See also Figure S3.
1164 Stem Cell Reports j Vol. 10 j 1160–1174 j March 13, 2018
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experimental groups compared with what is typically seen,
as in Figure 1C. Next, we tested satellite cell engraftment
function by xenotransplantation as described above. We
transplanted 2,000 HuSCs into irradiated TA muscles
and analyzed mice 5 weeks post transplantation for the
presence of human muscle fibers via human-specific
DYSTROPHIN staining. The engraftment of human fibers
was similar at the three experimental time points with an
average of greater than 100 human fibers at each time
point, demonstrating efficient engraftment of human fi-
bers from cells isolated from muscle up to 4 days after
removal from the body (Figures 3D and 3E). These findings
establish the feasibility of sample sharing andmore flexible
experimental planning and design.
Human Satellite Cells Engraft andProduceDystrophin
in Immunodeficient MDX Mice
To develop a model system for investigating HuSC trans-
plantation into dystrophic muscle, we adapted HuSC xen-
otransplantation to dystrophin-deficient hosts. The MDX
mouse is the most commonly used mouse model of
Duchenne muscular dystrophy (Bulfield et al., 1984; Di-
Mario et al., 1991; Dumont et al., 2015; Hoffman et al.,
1987; Straub et al., 1997). Although derived humanmuscle
cells and cultured muscle progenitors have been trans-
planted into different immunodeficient MDX mouse
strains (Chirieleison et al., 2012; Darabi et al., 2012; Goude-
nege et al., 2012; Meng et al., 2014), HuSCs have not. The
lack of a standard benchmark of endogenous HuSCs limits
interpretation and comparison of efficacy and stem cell
properties of transplanted cells from various sources. To
test the capacity of HuSCs to engraft human muscle in
the MDX mouse, we crossed MDX and NSG mice to
generate an NSG/MDX compound mutant line (see Exper-
imental Procedures). We transplanted HuSCs into 8-week-
old fifth-generation NSG/MDX mice, which were then
euthanized at 13 weeks, at which time the TA muscles
were processed and stained for analysis of human fiber
engraftment. The engraftment of human muscle andFigure 3. HuSC Isolation from Stored Muscle
(A) HuSCs were isolated as previously described from resected adult mu
or 4 days in 30% FBS at 4C. Representative flow-cytometry profiles
replicates). Cells gated are outlined in black within each plot. The pe
(B) Bar graph depicting the average number of HuSCs isolated per g
difference among the three groups (n = 3 biological replicates).
(C) Bar graphs demonstrating the average percentage of HuSCs adhe
statistically significant difference among the three groups (n = 3 bio
(D) Bar graph showing the number of humanmyofibers engrafted in eac
muscles with cells isolated on day 0 (n = 4), day 1 (n = 4), or day 4 (n
significant difference in the average engraftment of each condition.
(E) Representative images of human myofiber engraftment after xeno
Data presented as mean ± SEM. See also Figure S4.
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specific DYSTROPHIN staining (Figure 4A). Costaining
with human-specific DYSTROPHIN and pan-sensitive Dys-
trophin demonstrated several small foci of revertantmouse
fibers expressing Dystrophin as expected (Hoffman et al.,
1990). The presence of sublaminar, PAX7-positive HuSCs
was confirmed with SPECTRIN, PAX7, LAMIN A/C, and
Laminin staining, indicating repopulation of HuSCs in
the satellite cell niche (Figure 4B). To determine the average
engraftment of NSG/MDX transplanted with HuSCs, we
transplanted NSG/MDX TAs with 7,000 cells each (Fig-
ure 4C). Engraftment was similar to that observed in trans-
planted NSG mice and averaged 101 human fibers identi-
fied by human-specific DYSTROPHIN with a range of
50–148. This similarity did not merit formal direct compar-
ison of engraftment into NSG versus NSG/MDX back-
grounds. H&E evaluation of transplanted NSG/MDX TAs
demonstrated typical hallmarks of muscle degeneration
and regeneration (Bulfield et al., 1984) including frequent
centralized nuclei and a broad range of myofiber diameters
(Figure 4D). Engraftment of HuSCs in NSG/MDX and in
NSG muscle was similar in terms of efficiency of human-
derived fiber formation.
Human Satellite Cells Retain Phenotype and Function
after Cryopreservation
The scarcity of muscle tissue from human donors dictates
the availability and timing of experimentation with HuSCs
and significantly hinders HuSC research. We evaluated
whether HuSCs can be preserved with cryopreservation.
HuSCs were isolated as described previously (Figure 5A).
Sorted cells were then directly frozen in DMEM/F12 with
20% FBS, 13 insulin-transferrin-selenium (ITS), 13 gluta-
mine, 13 gentamicin, and 10% DMSO. After complete
preservation in vapor-phase nitrogen the cells were
thawed, stained, and reanalyzed with flow cytometry. After
thawing, HuSCs retained reactivity to CXCR4, CD29, and
CD56 antibodies (Figure 5B) and >75% of the cells were
viable based on live dead flow-cytometry assay with Sytoxscle either immediately after resection or after a storage period of 1
of HuSC isolation after each condition are shown (n = 3 biological
rcentage of events in each gating step is shown in each plot.
ram of muscle on each day processed. No statistically significant
ring onto Terasaki wells after isolation and seeding. There was no
logical replicates).
h mouse TA after xenotransplantation with 2,000 HuSCs into NSG TA
= 3) after biopsy (n values denote individual mice). There was no
transplantation (n = 3 biological replicates). Scale bar, 100 mm.
Figure 4. Xenotransplantation of HuSCs
into NSG/MDX Compound Mutant Mice
(A) Representative images of engrafted
human fibers in NSG/MDX TA muscle
after transplantation with HuSCs (n = 4
biological replicates). Left: human-specific
DYSTROPHIN. Right: costaining for human-
specific DYSTROPHIN and pan-sensitive
Dystrophin. Orange fibers represent cos-
taining and green fibers represent revertant
fibers. Scale bar, 100 mm.
(B) Representative images of HuSC
engraftment after transplantation into NSG/
MDX TA (n = 4 biological replicates). HuSCs
are denoted by sublaminar location and
expression of human-specific LAMIN A/C
and PAX7, marked by arrows. Scale bar,
10 mm.
(C) Bar graph showing quantification of hu-
man fiber engraftment in the NSG/MDX TAs
identified by human-specific DYSTROPHIN
staining (n = 4 individual mice). Data pre-
sented as mean ± SEM.
(D) Representative H&E of an NSG/MDX TA
cross-section after transplantation with
HuSCs (n = 4 biological replicates). Scale
bar, 100 mm.staining (Figure 5C). To test cryopreserved HuSC character-
istics, we directly compared cell size and mitochondrial ac-
tivity with that of cells from the same batch after culture for
48 hr (in DMEM/F12 with 20% FBS, 13 ITS, 13 glutamine,
13 gentamicin) and to freshly isolated HuSCs of the same
muscle type in the same experiment. The average size of
satellite cells from the freshly isolated, cryopreserved, or
48-hr culture groups were determined by forward scatter
on flow cytometry (Figures S5A–S5C) and also by Moxi
Flow, which showed average sizes of 8.21 ± 0.05 mm, 8.55
± 0.04 mm, and 8.58 ± 0.05 mm, respectively (Figure 5D).
The maximum diameters of each were 14 mm, 16.5 mm,
and 18 mm, respectively, with 1.35% of all cryopreserved
cells and 4.19% of all 48-hr culture cells larger than
14 mm. To assess the relative mitochondrial activity of the
cryopreserved satellite cells to freshly isolated cells, we per-formed a mitochondrial activity (MitoTracker) assay.
Freshly isolated satellite cells, cryopreserved satellite cells,
and 48-hr culture-activated satellite cells were stained
with MitoTracker green and analyzed by flow cytometry
as per the manufacturer’s instructions. Average mitochon-
drial activity and relative cell size were increased in the rela-
tive order 48-hr culture > cryopreserved > freshly isolated
cells (Figure 5E). Next, we compared the level of transcript
expression of the myogenic regulatory factors (MRFs)
MYF5,MYOD1, andMYOG, as well as PAX7 and the cell cy-
cle gene CDC45, among freshly isolated, cryopreserved,
and briefly cultured (48-hr) HuSCs (Figure 5F). The expres-
sion of these genes was not different between the freshly
isolated and cryopreserved groups. However, the expres-
sion of PAX7,MYF5, andMYOGwas lower in the 48-hr cul-
ture cells compared with both the freshly isolated andStem Cell Reports j Vol. 10 j 1160–1174 j March 13, 2018 1167
(legend on next page)
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cryopreserved cells.MYOD1 expression was lower in 48-hr
cells compared with cryopreserved cells. Although at 48 hr
of culture HuSCs have not yet proliferated significantly, the
expression of CDC45was higher in the 48-hr culture group
compared with both the freshly isolated and cryopreserved
groups. To assess retention of function, we next evaluated
the ability of the cryopreserved satellite cells to engraft
compared with freshly isolated cells from the same muscle
tissue (Figure 5G). Frozen satellite cells were thawed and re-
suspended in bupivacaine as with prior transplantations.
The cells were then transplanted into NSG TAs at a dose
of 2,000 cells per TA. Human fibers were identified by hu-
manDYSTROPHIN staining. Niche-associated, sublaminar,
human, and PAX7 positive satellite cells were identified in
each preparation using human-specific SPECTRIN, LAMIN
A/C, PAX7, and Laminin staining (Figures 5H and S5D).
When compared with freshly isolated HuSCs, cryopre-
served HuSCs engraft with the same efficiency (p = 0.361)
(Figure 5I). Collectively, these results show that cryopreser-
vation of HuSCs results in some alteration of cell size and
mitochondrial activity, but can be performed with reten-
tion of MRF expression levels and without loss of cell sur-
face marker expression or diminishment of engraftment
capacity.
Serial Isolation and Transplantation of Human
Satellite Cells
Serial transplantation is a quintessential experimental
measure of stem cell function that has not yet been demon-
strated for human muscle progenitors, leaving the exis-
tence of stem cell identities within the HuSC compartment
unproven. The lack of this experimental technique also
hinders direct comparison of regenerative potential amongFigure 5. HuSC Phenotype and Function after Cryopreservation
(A) Flow-cytometry profile of an HuSC isolation from the rectus abdo
(B) Isolated HuSCs (A) were cryopreserved and thawed, then restaine
each plot. The percentage of events in each gating step is shown in
(C) Sytox blue flow-cytometry profile for sorted satellite cells in (B) d
(D) Representative bar graph showing the average difference in satellit
cells (n = 490, 2,037, and 1,942 cells, respectively, from three biolog
(E) Representative histograms of freshly isolated satellite cells (orange
by MitoTracker flow-cytometry assay (n = 3 biological replicates).
Figure S5.
(F) Bar plots of qRT-PCR data comparing the expression of PAX7, MY
isolated, cryopreserved, and 48-hr cultured cell groups (n = 3). n Va
samples. Gene expression was normalized to the housekeeping gene
(G) Schematic depicting experimental approach to compare the eng
tissue.
(H) Representative images after transplantation with 2,000 cryoprese
the niche (right) with HuSCs (arrows) (n = 3 biological replicates). S
(I) Bar graph depicting the engraftment of human fibers after transpla
by human-specific DYSTROPHIN staining. There was no significant di
Data presented as mean ± SEM. See also Figure S5.different HuSCs. The enhanced HuSC isolation and xeno-
transplantation methods developed in this research
enabled us to test stem cell functions of transplanted
HuSCs, utilizing serial isolation and transplantation
(Figure 6A). Satellite cells isolated from adult human mus-
cle were transplanted into NSG mice and human cells
and muscle were allowed to engraft, return to quiescence,
and mature for 10 weeks, as we have previously reported
(Xu et al., 2015). After 10 weeks, mice were euthanized
and both transplanted TAs and contralateral control TAs
were digested and dissociated into single-cell suspensions.
Viable singlet cells were sorted by flow cytometry for
CD31/CD45/Sca1/CXCR4+/CD29+/CD56+ cells using
human-specific antibodies to detect CD56 and CD29 (Fig-
ure 6B). CXCR4/CD29/CD56 cells were found and isolated
from NSG muscle transplanted with donor cells but not in
contralateral control muscle. We isolated 200–1,400
CXCR4/CD29/CD56 HuSCs from each group of four mice
that were originally transplanted with 2,500–5,000 donor
satellite cells, representing an average recovery rate of
approximately 7% with a range of 1%–9%. After reisola-
tion, the satellite cells were transplanted into secondary
NSG mice and after 5 weeks the mice were euthanized to
assess for engraftment. Human muscle engraftment was
confirmed with human-specific DYSTROPHIN in both pri-
mary and secondary transplants, indicating preservation of
stem cell function through two rounds of transplantation.
Since repopulation of the niche and formation of human-
derived fibers was observed after two consecutive rounds
of isolation and transplantation, donor satellite cells re-
tained stem cell functions and may have undergone
self-renewal (Figure 6C). Alternatively, it is possible that a
subset of transplanted HuSCs remained quiescent duringminis muscle of a 43-year-old male.
d and sorted. In (A and B), cells gated are outlined in black within
each plot.
emonstrating >75% viability after cryopreservation.
e cell size among freshly isolated, cryopreserved, and 48-hr cultured
ical replicates). ***p < 0.001.
), cryopreserved cells (blue), and 48-hr cultured cells (red) assessed
‘‘Count’’ denotes number of cells. Complete profiles are shown in
F5, MYOD1, MYOG (n = 6), and CDC45 in satellite cells from freshly
lues denote technical replicates from two independent biological
RPS13.
raftment of cryopreserved and fresh HuSCs from the same muscle
rved HuSCs, of human fiber engraftment (left) and of repopulation
cale bars, 10 mm.
ntation with freshly isolated versus cryopreserved HuSCs quantified
fference in engraftment (n = 3 individual mice).
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Figure 6. Serial Isolation and Transplantation of HuSCs
(A) Schematic depicting the experimental design of serial isolation and transplantation of primary HuSCs. Syringe, cell suspension
injection; skull and crossbones, bupivacaine; hazard symbol, radiation.
(B) Representative flow-cytometry profiles of a primary reisolation. HuSCs are CXCR4/CD29/CD56-positive located within the outline in the
right plot and were only seen in muscle originally transplanted with donor HuSCs (bottom) compared with no HuSCs seen in digests from
contralateral control muscle (top) (n = 3). Cells gated are outlined in black within each plot. The percentage of events in each gating step is
shown in each plot.
(C) Representative image of human fiber formation in mice transplanted with primary reisolated HuSCs indicating engraftment (n = 3).
Scale bar, 100 mm.
(D) Images of HuSC repopulation of the satellite cell niche after secondary transplantation. Immunofluorescence staining for PAX7,
SPECTRIN, LAMIN A/C, and Laminin demonstrates human PAX7-positive cells in the sublaminar satellite cell niche in mice transplanted
with primary reisolated HuSCs (arrow) (n = 3). Scale bar, 10 mm.
All n values denote biological replicates.
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the first engraftment and was responsible for secondary
engraftment, without dividing. Definitive self-renewal as-
says during HuSC serial transplantation merit further
investigation. Although fewer human fibers per section
were detected in secondary recipients (83 ± 30 [primary
n = 5] versus 9 ± 3 [secondary n = 3]), engraftment effi-
ciency when corrected for the number of transplanted cells
did not differ significantly between primary and secondary
transplants (p = 0.984). This reflects the smaller number of
cells transplanted into secondary recipients, limited by
yield of recovery during reisolation.Moreover, we observed
an average of 1 PAX7-positive HuSC in the satellite cell
niche per 10 fibers per cross-section in both primary
and in secondary recipients, confirming both return to
quiescence and preservation of engraftment potency of
HuSCs that undergo one round of serial transplantation
(Figure 6D).DISCUSSION
The methods developed in this study reproducibly provide
robust yields of highly purified adult HuSCs from a wide
spectrum of cranial and somitic skeletal muscles. The tech-
niques resulted in first applications of classical experi-
mental stem cell paradigms to this endogenous cell popula-
tion. These advances, and the demonstrated feasibility of
muscle sample and HuSC storage, will make HuSCs widely
available to muscle stem cell researchers, enabling use of
minimally altered HuSCs for basic and translational
research.
Compared with prior studies we have improved HuSC
isolation to permit better separation of satellite cells, result-
ing in highly purified samples with little contamination of
non-satellite cells. Although significant variability of yield
persists, researchers can expect to obtain approximately
10,000 HuSCs from each gram of skeletal muscle processed
frommale or female individuals aged 41–60 years (Table S1
and Figure 1F), regardless of muscle type. Such is the case
for samples processed immediately or after storage for up
to 4 days, findings in agreement with prior work demon-
strating survival of muscle progenitors in postmortem
skeletal muscle (Latil et al., 2012), and show that although
absolute HuSC yield may decrease compared with fresh tis-
sue, robust yield is maintained and transplantability is pre-
served after storage. This will enable broader use and
sharing of human muscle samples. Future work should
further identify determinants of and minimize variability
of yield. Our experiments with tissue storage did not result
in detectable changes in HuSC function, suggesting that
alteredmetabolic state associated with a period of cold stor-
age does not diminish regenerative capacity. In contrast,
culture for even short periods without passaging alters pro-genitor properties such that engraftment capacity per cell is
greatly diminished. Whereas much work using human
muscle progenitors uses cultured human muscle cells (Bri-
mah et al., 2004; Cooper et al., 2001; Silva-Barbosa et al.,
2008; Skuk et al., 2010) and CD133+ cells (Meng et al.,
2014), which despite being expanded are uniformly altered
from their endogenous states, it is now feasible to perform
experiments with bona fide endogenous cells that retain
very high fidelity to satellite cells in their natural in vivo
states. This can be accomplished with purified HuSCs as
demonstrated in this study or with fiber-associated HuSC
as previously shown by us and others (Marg et al., 2014;
Xu et al., 2015). Minimally altered HuSCs will be useful
as a benchmark for other muscle progenitors in efforts to
recapitulate natural functions using derived or expanded
cells.
This report demonstrates reproducibility of satellite cell
preparation from 57 human skeletal muscle samples
weighing 6 g and under. Scalability should be readily
achievable with larger samples to achieve consistent yields
by uniform digestion and downstream processing. For
clinical application, the methods presented here can be
adapted to meet clinical requirements with compatible re-
agents. Based on current understanding of limitations of
prior clinical trials that used cultured muscle progenitors
(Miller et al., 1997; Partridge, 2002; Skuk et al., 2006),
readily available unpassaged HuSC preparations should
be expected to engraft, survive, and regenerate much
more robustly. Furthermore, cryopreservation will greatly
facilitate ex vivo manipulation such as genetic modifica-
tion, as well as repeated administration from the same
source. The previously established clinical availability of
large expendable human muscles indicates that preparing
adequate numbers of satellite cells for therapeutic trans-
plantation into smaller individual human muscles (e.g.,
face, extraocular, upper extremity, sphincter, and larynx)
is feasible without ex vivo expansion.
Availability of highly purified HuSCs readily enables new
experimental investigations. Cryopreservation permits
direct comparisons of cells that undergo disparate manipu-
lations without confounding factors of source variability
such as muscle type, and donor variables such as age,
gender, and other unknown factors that could differ
among individuals. Using cryopreserved cells will also
minimize unwanted experimental variables such as
unmatched transplant recipients, reagent batches, and
equipment variability that exist when experiments are per-
formed at different times. For example, we could assess
how culture affects HuSC mitochondrial activity by using
cryopreserved cells from the same sample, treated for
different lengths of time and then analyzed simulta-
neously. Serial transplantation will allow experimental
investigation of how in vivo regenerative capacity isStem Cell Reports j Vol. 10 j 1160–1174 j March 13, 2018 1171
affected in aged versus young samples, after pharmacolog-
ical manipulation and after genetic modification. It will
also enable comparative studies of heterogeneous HuSCs
separated by distinct surface markers. HuSC transplanta-
tion can be further used to study regenerative capacity
in vivo using reinjury expansion or by stimulation of regen-
eration in the NSG/MDX model. Finally, it is feasible to
explore the use of in vivo long-term incubation or expan-
sion of HuSCs in non-human animal hosts, a process that
could possibly preserve some natural characteristics and
functions relative to in vitro systems involving cryopreser-
vation or culture.
The improvements over existing technology were devel-
oped by empiric digestion and sorting strategies aimed at
achieving complete sample digestion and use of surface
marker combinations that allowed more rapid sorting
and better separation from contaminating cells. The addi-
tion of CXCR4 to the prior CD56/CD29 combination and
the negative selection greatly enhanced the efficiency of
flow cytometry and effectively removed non-satellite cells.
This advance will improve studies that rely on highly pure
satellite cell samples such as transcriptional analysis. We
also demonstrate that it is not necessarily advantageous
to use high numbers of satellite cells for transplantation.
Indeed, we show similar levels of human-derived fiber for-
mation after transplantation of hundreds of cells versus
tens of thousands, implying that with relatively pure pop-
ulations of satellite cells, engraftment is limited by niche
receptiveness or access in addition to satellite cell survival
or other factors affecting their ability to engraft, as sug-
gested by prior reports of high engraftment efficiency
from small numbers of HuSCs transplanted within their
niches on fibers (Marg et al., 2014; Xu et al., 2015). It re-
mains to be determined whether engrafted myonuclear
number can be further augmented by additional modifica-
tions or higher transplanted cell dosage, but the data pre-
sented in this study suggest that it may be possible to
perform experiments or clinical applications using small
amounts of starting human muscle tissue that can regen-
erate and expand in vivo with additional stimulation.EXPERIMENTAL PROCEDURES
Human Muscle Procurement
This studywas conducted under the approval of the Committee on
Human Research at The University of California, San Francisco
(UCSF). Biopsies were obtained from individuals undergoing sur-
gery at UCSF. Written informed consent was obtained from all
subjects.Animal Care and Transplantation Studies
All mice were bred and housed in a pathogen-free facility at UCSF.
All procedures were approved and performed in accordance with1172 Stem Cell Reports j Vol. 10 j 1160–1174 j March 13, 2018the UCSF Institutional Animal Care andUse Committee. All exper-
iments were unblinded and performed in 8- to 12-week-old NSG
mice (The Jackson Laboratory) and NSG mice crossed with MDX
mice (The Jackson Laboratory), creating NSG/MDX mice. Mice
were randomized to all experimental groups by sex and littermates
and were pretreated with 18 Gy on the day before transplantation.
HuSCswere injected alongwith 50 mL of 0.5%bupivacaine directly
into the TA muscle of one leg in a single injection or multiple in-
jections as indicated.
CXCR4+/CD29+/CD56+ Satellite Cell Sorting
Freshly harvested human muscle was either immediately digested
or stored in DMEM with 30% FBS at 4C. Muscle was digested,
erythrocytes lysed, and hematopoietic and endothelial cells
depleted with magnetic column depletion. Viable cells were
depleted for CD31-, CD34-, and CD45-expressing cells. Cells that
remained after depletion were sorted for CXCR4+/CD29+/CD56+
and collected for further experimentation.
PAX7 Immunostaining of Cells from Digested Muscle
Sorted cells were collected in 20% FBS-DMEMwith 10 mM ROCKi
and plated directly into wells of BioCoated laminin-coated cham-
ber slides (BD Biosciences). Slides were stained with monoclonal
rabbit anti-PAX7 antibody (1:500, Abcam) (see Figure S6 for anti-
body controls). Immunostaining antibodies are listed in Table S4.
Satellite Cell Cryopreservation
Satellite cells were suspended in DMEM/F12with 20% FBS, 13 ITS,
13 glutamine, 13 gentamicin, and 10%DMSO, frozen at a cooling
rate of 1C/min overnight and then moved to storage in vapor-
phase nitrogen. In this study, satellite cells were thawed and used
in experiments after 5 months of cryostorage.
qRT-PCR Analysis
Relative expression of individual genes compared with control
groups was calculated by the DD-Ct (delta-delta cycle threshold)
methodwithGAPDH or RPS13 as the housekeeping gene. qRT-PCR
primer sequences are available in Table S5.
Statistical Analysis
Normality of the data was checked utilizing the Shapiro-Wilk
normality test in GraphPad Prism.Means between or across groups
were compared using two-tailed t tests for experiments involving
two groups, or one-way ANOVA with post hoc Tukey multiple
comparisons when comparisons were made across three or more
groups to determine significance (p < 0.05) between test conditions
and controls, andmultiple groups. Multivariate regression was uti-
lized as indicated for comparing satellite cell yield per gram
controlling for age, gender, and muscle type. All human muscle
samples collected over the past year and processed within 12 hr
after biopsy were used for data analyses in Figure 1. At least three
mice per group were used for all transplantation experiments.
At least three biological replicates for each experiment were per-
formed unless otherwise noted, with exact n values listed in each
figure legend. All error bars are depicted as SEM. p values in figures
are indicated by asterisks (*p < 0.05, **p < 0.01, ***p < 0.001).
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